Fresenius SE Operating Expenses 2016-2024 | FSNUY

Fresenius SE annual/quarterly operating expenses history and growth rate from 2016 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Fresenius SE operating expenses for the quarter ending June 30, 2024 were $5.596B, a 47.72% decline year-over-year.
  • Fresenius SE operating expenses for the twelve months ending June 30, 2024 were $13.245B, a 67.46% decline year-over-year.
  • Fresenius SE annual operating expenses for 2023 were $22.897B, a 42.08% decline from 2022.
  • Fresenius SE annual operating expenses for 2022 were $39.53B, a 0.15% increase from 2021.
  • Fresenius SE annual operating expenses for 2021 were $39.471B, a 8.35% increase from 2020.
Fresenius SE Annual Operating Expenses
(Millions of US $)
2023 $22,897
2022 $39,530
2021 $39,471
2020 $36,430
2019 $34,471
2018 $33,398
2017 $33,114
2016 $27,395
2015 $26,373
Fresenius SE Quarterly Operating Expenses
(Millions of US $)
2024-06-30 $5,596
2024-03-31 $5,586
2023-12-31 $-3,566
2023-09-30 $5,629
2023-06-30 $10,703
2023-03-31 $10,131
2022-12-31 $10,232
2022-09-30 $9,641
2022-06-30 $9,762
2022-03-31 $9,896
2021-12-31 $10,136
2021-09-30 $9,806
2021-06-30 $9,910
2021-03-31 $9,618
2020-12-31 $9,884
2020-09-30 $9,124
2020-06-30 $8,585
2020-03-31 $8,837
2019-12-31 $8,922
2019-09-30 $8,577
2019-06-30 $8,591
2019-03-31 $8,382
2018-12-31 $8,695
2018-09-30 $8,314
2018-06-30 $7,679
2018-03-31 $8,709
2017-12-31 $8,956
2017-09-30 $8,442
2017-06-30 $8,101
2017-03-31 $7,615
2016-12-31 $7,078
2016-09-30 $6,924
2016-06-30 $6,824
2016-03-31 $6,570
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.458B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.988B 18.23
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00